Table 7.

Recommended Surveillance for Individuals with DNAJC6 Parkinson Disease

System/ConcernEvaluationFrequency
Movement
disorder
PT, OT, speech & language therapy evalsEvery 6 mos or more frequently as needed
Seizures Assess for new manifestations (e.g., seizures, changes in tone, movement disorders).At each visit
EEGAt 1st manifestation of symptoms, then as frequently as needed
Monitor those w/seizures as clinically indicated.Incl assessment & adjustment of anti-seizure medication as needed
Psychiatric
disorders
Psychiatric assessmentAt 1st manifestation of symptoms, then as frequently as needed
Sleep disorder Sleep study/polysomnography
Nutrition Growth assessmentAt each visit in children
Assessment of nutritional status to evaluate dietary requirementsAt each visit
Dysphagia Swallowing assessment to evaluate risk of aspirationAt 1st manifestation of symptoms, then as frequently as needed
Gastrointestinal
manifestations
Gastroenterology eval; gastroscopy if needed
Orthopedic
manifestations
Hip & spine radiographsEvery 6-12 mos in persons:
  • Who are nonambulatory at age >2 yrs
  • W/signs/symptoms concerning for spinal deformity
Vision deficits Ophthalmology evalAt 1st manifestation of symptoms, then as frequently as needed

OT = occupational therapy; PT = physical therapy

From: DNAJC6 Parkinson Disease

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.